These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

97 related articles for article (PubMed ID: 7865436)

  • 1. Intraperitoneal Taxol (paclitaxel) in the management of ovarian cancer.
    Markman M; Francis P; Rowinsky E; Hakes T; Reichman B; Jones W; Lewis JL; Rubin S; Curtin J; Barakat R
    Ann Oncol; 1994; 5 Suppl 6():S55-8. PubMed ID: 7865436
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Intraperitoneal administration of Taxol in the management of ovarian cancer.
    Markman M; Rowinsky E; Hakes T; Reichman B; Jones W; Lewis JL; Rubin S; Curtin J; Barakat R; Almadrones L
    J Natl Cancer Inst Monogr; 1993; (15):103-6. PubMed ID: 7912515
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Intraperitoneal paclitaxel in the management of ovarian cancer.
    Markman M
    Semin Oncol; 1995 Oct; 22(5 Suppl 12):86-7. PubMed ID: 7481868
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A phase I trial of intraperitoneal sustained-release paclitaxel microspheres (Paclimer) in recurrent ovarian cancer: a Gynecologic Oncology Group study.
    Armstrong DK; Fleming GF; Markman M; Bailey HH
    Gynecol Oncol; 2006 Nov; 103(2):391-6. PubMed ID: 16626792
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Phase I feasibility and pharmacologic study of weekly intraperitoneal paclitaxel: a Gynecologic Oncology Group pilot Study.
    Francis P; Rowinsky E; Schneider J; Hakes T; Hoskins W; Markman M
    J Clin Oncol; 1995 Dec; 13(12):2961-7. PubMed ID: 8523061
    [TBL] [Abstract][Full Text] [Related]  

  • 6. European-Canadian randomized trial of paclitaxel in relapsed ovarian cancer: high-dose versus low-dose and long versus short infusion.
    Eisenhauer EA; ten Bokkel Huinink WW; Swenerton KD; Gianni L; Myles J; van der Burg ME; Kerr I; Vermorken JB; Buser K; Colombo N
    J Clin Oncol; 1994 Dec; 12(12):2654-66. PubMed ID: 7989941
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Phase I dose-escalation trial of paclitaxel and ifosfamide in patients with advanced non-small cell lung cancer.
    Shepherd FA; Latreille J; Paul K; Eisenhauer E
    Semin Oncol; 1996 Dec; 23(6 Suppl 16):84-90. PubMed ID: 9007130
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Phase I trial of intraperitoneal taxol: a Gynecoloic Oncology Group study.
    Markman M; Rowinsky E; Hakes T; Reichman B; Jones W; Lewis JL; Rubin S; Curtin J; Barakat R; Phillips M
    J Clin Oncol; 1992 Sep; 10(9):1485-91. PubMed ID: 1355523
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Intraperitoneal paclitaxel: a possible role in the management of ovarian cancer?
    Markman M; Francis P; Rowinsky E; Hoskins W
    Semin Oncol; 1995 Jun; 22(3 Suppl 6):84-7. PubMed ID: 7597437
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Dose-escalated paclitaxel in 1-hour infusion with a fixed dose of cisplatin in previously untreated advanced ovarian cancer: a phase II trial of the Spanish Group for Ovarian Cancer.
    Cervantes A; Mendiola C; del Campo JM; Massuti B; Casado A; Escobedo A; Moyano A; Ojeda B; Poveda A; Benito D
    Semin Oncol; 1997 Oct; 24(5 Suppl 15):S15-40-S15-43. PubMed ID: 9346221
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Phase I clinical and pharmacokinetic study of taxol.
    Wiernik PH; Schwartz EL; Strauman JJ; Dutcher JP; Lipton RB; Paietta E
    Cancer Res; 1987 May; 47(9):2486-93. PubMed ID: 2882837
    [TBL] [Abstract][Full Text] [Related]  

  • 12. One-hour paclitaxel infusion schedules: a phase I/II comparative trial.
    Greco FA; Hainsworth JD
    Semin Oncol; 1995 Jun; 22(3 Suppl 6):118-23. PubMed ID: 7597427
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Paclitaxel combined with carboplatin in the first-line treatment of advanced ovarian cancer: a phase I trial.
    Meerpohl HG; du Bois A; Luck HJ; Kühnle H; Möbus V; Kreienberg R; Bauknecht T; Köchli O; Bochtler H; Diergarten K
    Semin Oncol; 1997 Feb; 24(1 Suppl 2):S2-17-S2-22. PubMed ID: 9045330
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Salvage weekly paclitaxel in recurrent ovarian cancer.
    Abu-Rustum NR; Aghajanian C; Barakat RR; Fennelly D; Shapiro F; Spriggs D
    Semin Oncol; 1997 Oct; 24(5 Suppl 15):S15-62-S15-67. PubMed ID: 9346225
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Carboplatin plus paclitaxel in the first-line treatment of advanced ovarian cancer: preliminary results of a phase I study.
    Lhommé C; Kerbrat P; Lejeune C; Guastalla JP; Fumoleau P; Goupil A; Héron JF; Cassin MA; Pruvot I; Soares JA; Chazard M
    Semin Oncol; 1996 Oct; 23(5 Suppl 12):48-54. PubMed ID: 8941410
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Phase I and pharmacological study of single paclitaxel administered weekly for heavily pre-treated patients with epithelial ovarian cancer.
    Takano M; Kikuchi Y; Kita T; Suzuki M; Ohwada M; Yamamoto T; Yamamoto K; Inoue H; Shimizu K
    Anticancer Res; 2002; 22(3):1833-8. PubMed ID: 12168878
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Intraperitoneal radioimmunochemotherapy of ovarian cancer: a phase I study.
    Meredith RF; Alvarez RD; Partridge EE; Khazaeli MB; Lin CY; Macey DJ; Austin JM; Kilgore LC; Grizzle WE; Schlom J; LoBuglio AF
    Cancer Biother Radiopharm; 2001 Aug; 16(4):305-15. PubMed ID: 11603001
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Pharmacologic study of intraperitoneal paclitaxel in gastric cancer patients with peritoneal dissemination].
    Fushida S; Furui N; Kinami S; Ninomiya I; Fujimura T; Nishimura G; Ohta T; Yokogawa K; Miyamoto K; Miwa K
    Gan To Kagaku Ryoho; 2002 Nov; 29(12):2164-7. PubMed ID: 12484028
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Intravenous prophylaxis for paclitaxel-related hypersensitivity reactions.
    Bookman MA; Kloth DD; Kover PE; Smolinski S; Ozols RF
    Semin Oncol; 1997 Dec; 24(6 Suppl 19):S19-13-S19-15. PubMed ID: 9427258
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Preliminary evaluation of a multicenter, randomized comparative study of TAXOL (paclitaxel) dose and infusion length in platinum-treated ovarian cancer. Canadian-European Taxol Cooperative Trial Group.
    ten Bokkel Huinink WW; Eisenhauer E; Swenerton K
    Cancer Treat Rev; 1993; 19 Suppl C():79-86. PubMed ID: 8106156
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.